Treatment simplification to atazanavir/ritonavir+lamivudine versus maintenance of atazanavir/ritonavir+two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M)

Atlas-M Study Group

Research output: Contribution to journalArticlepeer-review

Original languageUndefined/Unknown
Pages (from-to)1163-1171
Number of pages9
JournalJournal of Antimicrobial Chemotherapy
Issue number4
Publication statusPublished - Apr 1 2017

Cite this